The method of treatment of diseases of the visual analyzer

 

(57) Abstract:

The invention relates to medicine, namely to ophthalmology, and for the correction of functional disorders of the visual analyzer. To do this, use ritalin, which is injected through the irrigation catheter into the retro-bulbar space in 0.5 ml of 5 times per day after 3 h, additional intramuscularly Cortexin in 1.0 ml of 1 times a day, and spend svetonepronitsaemostyu of the visual analyzer in combination with the training of the accommodation on the computer one session per day, the course of treatment is 10 days. The method can improve visual function, ensuring a consistent effect.

The invention relates to medicine, and more specifically to ophthalmology, and can be used for the treatment of acute and chronic diseases of the visual analyzer.

There is a method of treatment of diseases of the visual analyzer (E. I. Sidorenko, T. C. Pavlov. Current issues in pediatric ophthalmology. - Moscow, 1997 , S. 161-3. ) by alternately introducing into the retro-bulbar space of medicines through the irrigation catheter with the purpose of dehydrating and anti-inflammatory therapy, inhibition of proteolysis and angioprotectors and Saratov and shown in the acute stage of the disease.

The objective of the invention is to provide a method of treatment of diseases of the optic analyzer, providing a lasting effect and improvement of visual functions.

The technical result according to the invention is achieved by a method for the treatment of diseases of the optic analyzer includes an introduction into the retro-bulbar space through the irrigation catheter of ritilin 0.5 ml of 5 times a day, 3 hours, intramuscular administration of Cortexin in 1.0 ml of 1 times in day on the background of svetonepronitsaemostyu in combination with the training of the accommodation on the computer one session per day, the course of treatment is 10 days.

According to the invention using ritalin and Cortexin - peptide bioregulators.

Retin-a is one of the main tissues of the visual analyzer, which provides high visual function.

However, even anatomical preservation it does not guarantee high visual acuity, for example, when amblyopia in children.

Sharp changes in the metabolism of cells of the retina when the damaging influence of various factors cause a significant reduction in visual function.

Currently, there are practically no effective medications, the incentive is bioregulatory control gene expression and protein synthesis, what prevents the accumulation of structural and functional changes, which determine the transition of biological systems from the normal state to the abnormal.

Peptide bioregulators isolated from the organs and tissues of animals; drug Cortexin is prepared on the basis of the peptides of the cerebral cortex, and ritilin from peptides of the retina of the eyes of cattle. Ritalin has tissue-specific effects on the retina, has a stimulating effect on the photoreceptors and cellular elements of the retina, improve functional interaction of the pigment epithelium and outer segments of photoreceptors, accelerates restoration of light sensitivity of the retina.

Cortexin has contraproductive, nootropic effect, stimulates reparative processes in the brain.

In the retro-bulbar space through the irrigation catheter according to the invention introduce ritilin 0.5 mm to 5 times a day 3 hours and intramuscularly injected Cortexin in 1.0 ml of 1 times a day.

For the course of the magnetic and light stimulation using the apparatus of Mecoptera MS-7 (manufactured ETP "eye microsurgery" in collaboration with NPL "Megaptera" , Mosquee work light emitter is directed to the eye and fixed by means of specialized eyeglass frames. Magnetic inductive emitter is held by hand at the impact zone. The emitters simultaneously connected to the control unit for carrying out a synchronous magnetic stimulation and focused lit the retina at which the magnetic pulse is generated with a delay with respect to a short light pulse.

The delay time is set for the zones of influence in accordance with the delay in the propagation of excitation along the optic nerve. This provides a mutual enhancement of the light and magnetic stimulation. Using the control unit sets the frequency and the delay time of the pulses, the duration of the sessions of the magnetic light stimulation.

Video computer auto-training is carried out using a software package to the computer type i BM PC AT providing a synthesis of color and monochrome images of test objects, size, shape, location, and movement speed which can vary within wide limits depending on the set before the patient's medical problem, his age and pathology of the visual analyzer.

Clinical example.

Patient B., aged 14. Diagnosis: anisometropia, hyperopia high degree of amlip the fundus of the Eye for no apparent focal pathology.

Completed the treatment according to the invention, through the irrigation catheter into the retro-bulbar space entered peptide biostimulant - ritalin 0.5 ml to 5 times a day in 3 hours, and the other peptide biostimulant Cortexin was introduced intramuscularly in a dose of 10 ml of 1 times a day.

Every day svetlaniny stimulation in combination with training accommodation on the computer one of each type of treatment. The course of treatment is 10 days.

At the end of treatment:

visual acuity 0,04 sh + 6,0 = 0,125 n/Nord.

After 1.5 years of treatment effect remained.

The method of treatment of diseases of the visual analyzer, comprising the administration of a medicinal product into the retro-bulbar space, characterized in that as a drug use ritalin, which is injected through the irrigation catheter of 0.5 ml of 5 times per day after 3 h, additional intramuscularly Cortexin in 1.0 ml of 1 times in day on the background of svetonepronitsaemostyu in combination with the training of the accommodation on the computer one session per day, the course of treatment is 10 days.

 

Same patents:

The invention relates to medicine, in particular to ophthalmology, and is intended to improve the treatment results of patients with blunt trauma of the eyeball, complicated intraocular hemorrhage

-converting enzyme)" target="_blank">

The invention relates to novel ortho-sulfonamidophenylhydrazine heteroaryl hydroxamic acids of the formula

< / BR>
where W and X are both carbon, T is nitrogen, U represents CR1where R1represents hydrogen, or alkyl containing 1-8 carbon atoms, R represents-N(CH2R5)-SO2Z, Q represents -(C=O)-NHOH, with

< / BR>
is a benzene ring, or is a heteroaryl ring of 5 to 6 atoms in the cycle, which may contain 0-2 heteroatoms selected from nitrogen, oxygen and sulfur, in addition to the heteroatom of nitrogen, denoted as W, where benzene or heteroaryl ring may optionally contain one or two substituent R1where permissible; Z is phenyl, which is optionally substituted by phenyl, alkyl with 1-8 carbon atoms, or a group OR2; R1represents halogen, alkyl with 1-8 carbon atoms, alkenyl with 2-6 carbon atoms, perfluoroalkyl from 1 to 4 carbon atoms, phenyl, optionally substituted by 1-2 groups OR2group-NO2group -(CH2)nZ, where Z is a phenyl which allows an alkyl with 1-8 carbon atoms, phenyl, optionally substituted with halogen, or heteroaryl radical containing 5 to 6 atoms in the cycle, including 1-2 heteroatoms selected from nitrogen, oxygen and sulfur; R5represents hydrogen, alkyl with 1-8 carbon atoms, phenyl, or heteroaryl containing 5 to 6 atoms in the cycle, including 1-2 heteroatoms selected from nitrogen, oxygen and sulfur; or their pharmaceutically acceptable salts
The invention relates to medicine, namely to ophthalmology, and for the treatment of diabetic retinopathy
The invention relates to the field of medicine

The invention relates to medicine, namely to ophthalmology, and for the prevention of recurrence of erosion and ulceration of the cornea on the eye ended with the healing of burn wounds with bilateral burns after keratoplasty about ulceration of the cornea of one eye

The invention relates to medicine, namely to ophthalmology, and for the treatment of serotonin deficiency in patients with diabetic retinopathy
The invention relates to medicine, namely to ophthalmology, and for the treatment of bullous keratopathy
The invention relates to medicine, namely to ophthalmology and for the treatment of herpetic eye lesions

The invention relates to medicine, namely to ophthalmology
The invention relates to the field of medicine
The invention relates to medicine, namely to methods of therapeutic effects on the human body
The invention relates to medicine, in particular to methods of treatment of alcoholism and drug abuse

The invention relates to medicine, in particular to urology
The invention relates to medicine and can be used in the treatment of male infertility

The invention relates to medicine and veterinary medicine and can be used for reflexology and local UV irradiation of the surface of the body of humans and animals

The invention relates to ophthalmology, and can be used when conducting laser stimulation of the ciliary muscle
The invention relates to medicine and can be used for the treatment of malignant lesions of the pleura
The invention relates to medicine and can be used in the treatment of malignant tumors
The invention relates to medicine, namely to Phthisiology
The invention relates to medicine, in particular to the experimental gastroenterology, and can be used for pathogenetic treatment of chronic liver diseases in the experiment

The invention relates to the field of medical technology and can be used to create equipment for magnetotherapy impact, intended for therapeutic and rehabilitation procedures
Up!